Akebia Therapeutics is a American stock, trading under the symbol AKBA-Q on the NASDAQ (AKBA). It is usually referred to as NASDAQ:AKBA or AKBA-Q
In the last year, 1 stock analyst published opinions about AKBA-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Akebia Therapeutics.
Akebia Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Akebia Therapeutics.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Akebia Therapeutics published on Stockchase.
On 2022-05-25, Akebia Therapeutics (AKBA-Q) stock closed at a price of $0.33.